Rewriting the Neurobiology of Autism, One Symptom at a Time

  • At Remi Therapeutics, we are transforming the treatment paradigm. Instead of suppressing an individuals spirit with antipsychotics or masking symptoms, we develop therapies that restore core neurological function.
  • Our novel first-in-class small molecule are designed to break the cycles of neuroinflammation and oxidative stress that disrupt learning, attention, mood, and motor function in autism and related conditions.
  • By matching drug design to the underlying biology of specific symptom domains such as cognition, emotional regulation, and neuromuscular resilience—we are creating treatments that are more precise, more humane, and more effective.
View Our Pipeline

Why Remi Therapeutics Is Poised to Lead

Remi Therapeutics is advancing a new generation of autism treatments built around biology, not just behavior.

Our pipeline targets the root causes of ASD including oxidative stress, inflammation, and disrupted neurotransmitter signaling. Each program is tuned to a specific functional domain such as cognition, mood, or motor coordination

Our Advantage

  • 01

    Addressing a Massive, Unmet Need

    1 in 31 individuals are diagnosed with autism, yet no approved therapies target its core symptoms. Remi is developing precision treatments designed to improve how individuals think, communicate, and function every day

  • 02

    Biology-First Approach to Neurodevelopmental Disease

    Our therapeutics break the cycle of oxidative stress and neuroinflammation that disrupts cognition, focus, and motor coordination in ASD

  • 03

    First-In-Class ASD Medications With The Potential to Expand

    Each of our compounds targets a specific symptom domain, such as executive function or motor coordination, with clear opportunities to expand into related conditions like ADHD and sarcopenia.

  • 04

    Strong Translational Science with Proprietary Models

    Our assets were discovered through phenotype-based screens using the latest translational models for ASD which include hyperactivity, cognitive and social hyper-reactivity

Innovating Today for a Better Tomorrow

Every therapy in our pipeline is grounded in biology and built with families in mind. We target the core challenges that shape daily life: cognition, mood, and movement; so children can thrive and families can reconnect.

The Reality of Autism

Creating Impact Where It Matters Most

Autism affects how a child learns, moves, connects, and lives. Yet there are still no FDA-approved treatments for the core symptoms of Autism Spectrum Disorder (ASD).

Instead, families are often left with antipsychotics—blunt tools designed to suppress behavior, not restore function. These medications can dull personality, disrupt metabolism, and overlook the biology driving daily struggles.

Meanwhile, the cost of autism continues to rise—exceeding $268 billion annually and expected to surpass $1 trillion by 2040.

We believe it’s time for something better.

Remi Therapeutics is advancing treatments that target the root causes of autism—neuroinflammation, oxidative stress, and neurotransmitter imbalance—so that children can learn, grow, and thrive.

  • 1 in 31

    Children diagnosed with Autism in the U.S.

  • 6.1 million

    Children diagnosed with ADHD in the U.S. alone

Break the Cycle. Heal the System

In autism spectrum disorder (ASD), oxidative stress, neuroinflammation, and neurotransmitter imbalance create a self-perpetuating loop of dysfunction.
Remi Therapeutics is developing therapies that interrupt this loop—restoring neurological stability and unlocking meaningful improvements in learning, behavior, and daily life.

Learn More